Gensight share price
WebInformation on stock, financials, earnings, subsidiaries, investors, and executives for GenSight Biologics. Use the PitchBook Platform to explore the full profile. Information on stock, financials, earnings, subsidiaries, investors, and executives for GenSight Biologics. ... Share Price; $3.48 (As of Friday Closing) ... Stock Price Previous ... WebGenSight Biologics S.A. (SIGHT) EUR0.025 Sell: €2.34 Buy: €2.40 €0.19 (8.92%) Market closed Prices as at close on 31 March 2024 Turn on streaming prices Add to watchlist This stock can be...
Gensight share price
Did you know?
WebFeb 5, 2024 · Summary of all time highs, changes and price drops for GenSight Biologics; Historical stock prices; Current Share Price: €2.30: 52 Week High: €4.59 WebJan 19, 2024 · What is the Gensight Biologics stock price / share price today? The Gensight ... You'll find the Gensight Biologics share forecasts, stock quote and buy / sell signals below. According to present data Gensight Biologics's GSGTF shares and potentially its market environment have been in bearish cycle last 12 months (if exists).
WebApr 3, 2024 · Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. GenSight Biologics S.A. (GSGTF) Stock Price Today, … WebApr 8, 2024 · The Company’s net loss in 2024 amounted to €28.6 million compared to €34.0 million in 2024. The average weighted number of shares increased to 45.2 million in 2024 from 35.1 million in 2024 leading...
WebApr 21, 2024 · Cash position as of March 31, 2024. GenSight Biologics’ cash and cash equivalents totaled €36.0 million as of March 31, 2024, compared to €44.3 million as of December 31, 2024. The operating ... WebMar 23, 2024 · Latest Gensight Biologics SA (SIGHT:PAR) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. …
WebOver the last year, Gensight Biolog share price has been traded in a range of 2.317, hitting a high of 4.12, and a low of 1.803. Intraday Gensight Biolog Share Chart Gensight …
WebDec 23, 2024 · GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative... hudlege myhre asWebFeb 28, 2024 · GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative... hudlege richard stollWebMar 28, 2024 · finance.yahoo.com - November 17 at 1:51 AM. GenSight Biologics Secures a €35 Million Credit Facility From the European Investment Bank to Support the Launch of LUMEVOQ® in Europe. finance.yahoo.com - November 4 at 9:39 AM. GenSight Biologics Reports Cash Position and Revenues as of September 30, 2024. finance.yahoo.com - … hudl editingWebStock analysis for GenSight Biologics SA (SIGHT:EN Paris) including stock price, stock chart, company news, key statistics, fundamentals and company profile. hudl editing softwareWebApr 9, 2024 · The MarketWatch News Department was not involved in the creation of this content. Apr 09, 2024 (The Expresswire) -- Strategy Execution Management Solution Market Size 2024-2030 New Report (103 ... hudlege freddy hestholmWebMar 8, 2024 · The PPQ campaign is now expected to begin in May 2024 instead of March with results expected in Q3 2024. GenSight’s share price dropped 32% following the news. “Even if limited, I deeply regret this additional delay,” said enSight CEO Bernard Gilly in … holc picturesWebThe latest GenSight Biologics S.A. EUR0.025 share price. View recent trades and share price information for GenSight Biologics S.A. EUR0.025 holc relief recovery or reform